OpenAlex
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Work
Year: 2022
Type: article
Abstract: Antitumor activity in preclinical models and a phase I study of patients with dedifferentiated liposarcoma (DD-LPS) was observed with selinexor. We evaluated the clinical benefit of selinexor in patie... more
Cites: 32
Cited by: 27
Related to: 10
FWCI: 6.057
Citation percentile (by year/subfield): 84.82
Field: Medicine
Sustainable Development Goal Good health and well-being
Open Access status: hybrid